208 related articles for article (PubMed ID: 35822433)
1. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
4. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
5. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature.
Sheng J; Pan H; Han W
Front Immunol; 2023; 14():1181444. PubMed ID: 37153561
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract][Full Text] [Related]
7. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.
Huey RW; Makawita S; Xiao L; Matamoros A; Estrella JS; Overman MJ; Varadhachary GR; Raghav K
BMC Cancer; 2019 Oct; 19(1):965. PubMed ID: 31623602
[TBL] [Abstract][Full Text] [Related]
9. Unknown primary adenocarcinomas: a single-center experience.
Uzunoglu S; Erdogan B; Kodaz H; Cinkaya A; Turkmen E; Hacibekiroglu I; Sari A; Ozen A; Usta U; Cicin I
Bosn J Basic Med Sci; 2016 Nov; 16(4):292-297. PubMed ID: 27455119
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
11. Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature.
Petrakis D; Pentheroudakis G; Voulgaris E; Pavlidis N
Cancer Treat Rev; 2013 Nov; 39(7):701-8. PubMed ID: 23566573
[TBL] [Abstract][Full Text] [Related]
12. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
14. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute.
Fehri R; Rifi H; Alboueiri A; Malouche D; Ayadi M; Rais H; Mezlini A
Tunis Med; 2013 Mar; 91(3):205-8. PubMed ID: 23588636
[TBL] [Abstract][Full Text] [Related]
16. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
18. Bone metastatic cancer of unknown primary at initial presentation.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
[TBL] [Abstract][Full Text] [Related]
19. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]